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Abstract The characteristics of mitochondria of yeast cells 
expressing the pro-apoptotic gene Bax or coexpressing Bax and 
the anti-apoptotic gene BC1-XL have been investigated in whole 
cells, isolated mitochondria and permeabilized spheroplasts. It is 
found that Bax-induced growth arrest of yeast cells is related to 
two defects in the respiratory chain: (i) a decrease in the amount 
of cytochrome c oxidase, the terminal enzyme of the respiratory 
chain, and (ii) a dramatic increase in the release of cytochrome c 
to the cytosol. Other components of the inner mitochondrial 
membrane (bei complex and F0Fi-ATPase) are unaffected. 
Coexpression of BC1-XL almost fully prevented the effect of Bax. 
Surprisingly, these results obtained in yeast parallel similar 
observations reported in mammalian cells. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The Bcl-2 gene product is a potent inhibitor of apoptotic 
cell death [1]. It is a member of the growing family of Bcl-2-
like proteins, some of which inhibit apoptosis (e.g. BCI-XL, the 
long form of Bcl-x [2]), while others are involved in inducing 
apoptosis (e.g. Bax [3]). There exist in invertebrates proteins 
that are similar to members of the Bcl-2 family (e.g. ced9, the 
Bcl-2 homolog in Caenorhabiditis elegans [4]). Until now, pro-
teins similar to Bcl-2 or Bax have not been found in lower 
eukaryotes, such as the yeast Saccharomyces cerevisiae. Ac-
cordingly, no phenomenon resembling apoptosis has been de-
scribed in yeast until now. 
Yeast is a powerful tool for studying the molecular mech-
anism of action of human proteins. The two-hybrid system 
has been used to identify putative interactions between pro-
teins encoded by the genes of the Bcl-2 family [5,6]. Moreover, 
it was recently found that expression of Bax interferes with 
yeast cell growth. This unexpected inhibition of growth is 
prevented by coexpression of the anti-apoptotic genes Bcl-2 
or BCI-XL. However, growth arrest induced by Bax expression 
is not associated with any apoptosis-associated characteristics, 
such as oligonucleosomal DNA-fragmentation [7]. Impor-
tantly, it was found that the presence of fully active mitochon-
dria is required for both the deleterious effect of Bax and the 
protective effect of Bcl-2 [8]. 
It is suspected that mitochondria play a crucial role in the 
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effects of the Bcl-2 family of genes in mammalian cells. When 
overexpressed, Bcl-2 is localized, although not exclusively, to 
the outer mitochondrial membrane [9]. Different hypotheses, 
based on observations made in diverse model systems, have 
been put forward to explain the role of mitochondria in apop-
tosis. One hypothesis involves the so-called permeability tran-
sition pore, a large mitochondrial megachannel whose open-
ing is induced by Ca2+ and oxidative agents. Opening of the 
pore is able to release most molecules below 1500 daltons, 
including Ca2+ itself ([10], for a review), from the inner mi-
tochondrial matrix which then leads to apoptosis. The drop in 
mitochondrial membrane potential (ΔΨ), caused by the open-
ing of the system with pro-oxidants, is inhibited by cyclospor-
in A or bongkrekic acid thus preventing apoptosis [11]. An-
other set of observations involves cytochrome c, a soluble 
protein loosely bound to the outer face of the inner mitochon-
drial membrane. Recent evidence from two different groups 
show that release of cytochrome c to the cytosol is required 
for activation of the protease CPP32, an event that probably 
occurs in all cells undergoing apoptosis [12,13]. Moreover, it 
has been shown that Bcl-2 acts on mitochondria to prevent 
cytochrome c release. A third hypothesis involves Raf-1, a 
kinase of the ras family, which is targeted by Bcl-2 to the 
mitochondria. Mitochondria-associated Raf-1 probably phos-
phorylates the pro-apoptotic protein BAD (another Bcl-2 
family protein) or other protein substrates to protect cells 
from apoptosis [14]. 
In this communication, we characterize the Bax-induced 
growth arrest phenotype in yeast cells at the mitochondrial 
level. We find that Bax expression stimulates the release of 
cytochrome c to the cytosol and causes a concomitant de-
crease in the amount of cytochrome c oxidase complex. How-
ever, the bei complex and the FoFi-ATPase are not affected. 
Interestingly, release of cytochrome c and decrease in the 
amount of cytochrome c oxidase can be nearly completely 
prevented by coexpression of BCI-XL-
2. Materials and methods 
The construction of yeast strains expressing Bax and BCI-XL under 
the control of GALIO promoter has been described previously [8]. 
Briefly, a construction carrying a chemically synthesized human bax 
gene (with yeast codon bias) fused to a GALIO promoter and a SUC2 
transcription terminator fragment was integrated at the LEU2 locus 
of the wild-type strain HT444 (MATa, leu2-3, leu2-112, his4-519, ura3, 
lys2). The strain obtained after integration is referred to as Bi (i.e. Bax 
integrant). Bi was transformed with a CEN-plasmid encoding the Bcl-
XL gene that is also fused to the GALIO promoter and the SUC2 
terminator. The CEN-plasmid carries the URA3 gene as yeast selec-
tion marker. The transformed strain is referred as BÍ/BC1-XL· In all 
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Fig. 1. Cytochrome spectra on whole cells (A), isolated mitochondria (B), and on the pellet (C), supernatant (D) of permeabilized spheroplasts. 
A: Cells were grown in YP 2% lactate medium until mid-exponential growth phase and then 0.5% galactose was added. Cells were harvested 
and washed twice with water. The cell suspension (OD550nm = 30) was then displayed in the cuvettes of an Aminco DW2000 spectrophotometer 
and the dithionite-reduced vs. H202-oxidized spectra were recorded. B: Mitochondria were isolated from cells grown as described under Table 
1. C, D: Mitochondria suspension was adjusted at 2 mg/ml. Cells were grown until late-exponential growth phase in a YP medium supple-
mented with 0.5% lactate. Then 0.25% galactose was added and cells were allowed to grow for another 4 h. Spheroplasts were prepared accord-
ing to [16]. Spheroplasts were diluted to 5 mg/ml in a 10 mM potassium phosphate buffer (pH 6.8) containing 1 M sorbitol, 2 mM EGTA, 
0.1% BSA. After addition of 50 μg nystatin/mg, spheroplasts were incubated for 10 min at 28°C. After a 3 min centrifugation at 12 000Xg, cy-
tochrome spectra were recorded both on the supernatant (D) and on the pellet resuspended in 1 ml water (C). For all recordings, the vertical 
bar represents 0.02 OD units, a, HT444; b, Bi; c, Bi/Bcl-xL. 
experiments, HT444, Bi and BÍ/BC1-XL were pre-grown in minimal 
medium (containing yeast nitrogen base) with 2% glucose as carbon 
source and auxotrophic requirements. The cells were washed and 
transferred into complete medium (YP) that contained 1% yeast ex-
tract, 0.5% gelatin hydrolysate, 0.1% potassium phosphate, 0.12% 
ammonium sulfate, 0.5% or 2% (DL)-lactate, pH 5.0 with NaOH, 
Table 1 
Cellular and mitochondrial bioenergetic parameters 
HT444 Bi Bi/Bcl-xL 
ODmax550llm in YNB lact. 2% 
ODmax55onm in YNB lact. 2%+gal. 0.5% 
OOm&xii0ma in YP lact. 2% 
ODmax5B0mn in YP lact. 2%+gal. 0.5% 
cytochrome b (pmol/mg) 
cytochromes a+a3 (pmol/mg) 
cytochromes c+ci (pmol/mg) 
N A D H ^ 0 2 (state 4) (nat.O/min/mg) 
N A D H ^ 0 2 (state 3) (nat.O/min/mg) 
Ethanol -> Fe(CN)e (nmol/min/mg) 
Ethanol -> cytochrome c (nmol/min/mg) 
ATPase activity (nmol/min/mg) 
% oligomycin sensitivity 
3.6 
7.7 
11.8 
15.1 
444 ±50 
90 ±12 
602 ±42 
348 ±12 
749 ±24 
840 ±82 
102 ±13 
800 ±26 
60 ±12 
4.1 
1.4 
11.6 
5.8 
339 ±42 
6 ± 6 
197 ±21 
88 ±17 
84 ±10 
320 ±25 
129 ±5 
806 ±18 
49 ±10 
3.5 
7.1 
12.3 
15.7 
437 ±48 
45 ±15 
569 ± 53 
404 ±21 
768 ±31 
765 ± 80 
129 ±8 
798 ±20 
45 ±7 
Cell growth: Cells were inoculated into YNB or YP liquid media supplemented with 2% lactate and grown until 0.5-0.7 OD550nm units. Then 0.5% 
galactose was added or not and cultures were let grown until reaching maximal OD550nm- The error on this value was less than 0.2 OD550nm units. 
Mitochondrial bioenergetic parameters: Cells were grown in YP medium supplemented with 2% lactate until late-exponential growth phase, 0.5% 
galactose was added and cells were allowed to grow for 4 additional hours. Mitochondria were then isolated as described in [15]. All measurements 
(except ATPase) were made in a 10 mM Tris-maleate buffer (pH 6.8) containing 0.6 M mannitol, 2 mM EGTA and 0.3% BSA. 
For cytochromes: Mitochondria were suspended at 4 mg/ml and the dithionite-reduced vs. H202-oxidized spectra were recorded in an Aminco 
DW2000 spectrophotometer. 
For N A D H - > 0 2 : Mitochondria were suspended at 0.67 mg/ml in the buffer containing 5 mM phosphate and oxygen consumption was monitored 
with a Clark-type electrode; 2 mM NADH was used as the respiratory substrate; state 3 was obtained after addition of 1 mM ADP. 
For ethanol->Fe(CN)6: Mitochondria were suspended at 0.5 mg/ml in the presence of 1 mM potassium ferricyanide and 1 mM potassium cyanide. 
The reduction of ferricyanide by 20 mM ethanol was measured as the change of absorbance at 420 nm minus 470 nm. 
For ethanol-»cytochrome c: Mitochondria were suspended at 0.25 mg/ml in the presence of 13 μΜ yeast cytochrome c and 1 mM potassium 
cyanide. The reduction of cytochrome c by 20 mM ethanol was measured as the change of absorbance at 550 nm minus 540 nm. 
For ATPase activity: Mitochondria (1 mg/ml) were suspended in a 0.2 M KC1, 5 mM MgCl2, 10 mM Tris-HCl buffer (pH 8.4). The reaction was 
started by the addition of 5 mM ATP and stopped by the addition of 0.3 M trichloroacetic acid. After centrifugation, phosphate was measured in 
the supernatant by a colorimetric method. Oligomycin was added at 10 μg/mg protein. 
All data in this table were obtained on a single mitochondria preparation for each strain and were reproducibly obtained from three different 
mitochondria preparations (two for HT444). 
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and were grown until late-exponential growth phase. The expression 
of Bax or Bax/Bcl-XL was induced by growth of cells for 4 h after 
addition of 0.25% or 0.5% galactose. 
Mitochondria were isolated as described in [15]. Spheroplasts were 
prepared and permeabilized as described in [16]. Proteins were meas-
ured with the biuret method. Spectra of cytochromes were recorded in 
an Aminco DW2000 double-beam spectrophotometer on dithionite-
reduced vs. H202-oxidized samples. Oxygen consumption, ATPase 
activity and bei complex activity are detailed in the legend of Table 1. 
All reagents were obtained from Sigma/Aldrich. 
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Strains and growth conditions 
Fig. 3. Cytochrome c release in permeabilized spheroplasts. Cells 
were grown in YP medium supplemented with 0.5% lactate until 
late-exponential growth phase. Then 0.25% galactose or 5 g/1 chlor-
amphenicol was added. Measurements of cytochromes were per-
formed as described under Fig. IC, D. Results represent the % of 
cytochrome c found in the supernatant. Each value is means ± S.D. 
of 3 to 6 independent preparations. HT444: wild-type grown in the 
absence of galactose; Bi(ni): Bi grown in the absence of galactose; 
Bi(cap): Bi grown in the presence of chloramphenicol; Bi(gal): Bi 
grown in the presence of galactose; Bcl-x(cap): BÍ/BC1-XL grown in 
the presence of chloramphenicol; bclX(gal): BÍ/BC1-XL grown in the 
presence of galactose. 
3. Results and discussion 
Cytochrome b 
0 10 20 
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Cytochrome a+a3 
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Fig. 2. Amounts of cytochromes in Bi (squares) and BÍ/BC1-XL (tri-
angles) cells following induction in galactose. Similar conditions as 
in Fig. 1A were used. Cytochrome c, cytochrome b and cytochrome 
a+a3 were quantified by the difference in absorbance at 550 nm mi-
nus 540 nm, 561 nm minus 575 nm and 603 nm minus 630 nm and 
expressed as the ratio of the amount of cytochromes after galactose 
induction over the amount of cytochromes before induction. Results 
are representatives of three similar experiments. 
The phenomenon of growth arrest induced by Bax expres-
sion is illustrated in Table 1, where the maximal OD reached 
by the cultures of the wild-type strain HT444, the Bax-ex-
pressing strain and the Bax/Bcl-XL-coexpressing strain are re-
ported. It appears clearly that expression of Bax completely 
stops the growth of yeast cells. Cell growth is restored again 
by coexpression of BC1-XL. 
Cytochrome spectra were recorded on whole cells to depict 
alterations of the respiratory chain (Figs. 1A and 2). It ap-
pears that expression of Bax induces a decrease in the amount 
of cytochromes a+a3 whereas levels of cytochromes b and 
c+ci were not similarly affected. It should be noted that, 
although the coexpression of BC1-XL prevents the disappear-
ance of cytochromes a+a3, it does not fully restore the normal 
amount of cytochrome a+a3 found in wild-type cells (this 
appears more clearly on isolated mitochondria, see below). 
Mitochondria were isolated from cells grown on a medium 
supplemented with 2% (DL)-lactate until the late-exponential 
growth phase (OD55onm = 2-2.5). 0.5% galactose was added 
and cells were grown further for another 4 h. Recordings of 
cytochrome on mitochondria (Fig. 2B) confirmed the almost 
complete disappearance of cytochrome a+a3 and insensitivity 
of cytochrome b to Bax expression. But an additional phe-
nomenon was evidenced: mitochondria from cells expressing 
Bax lost most of their cytochrome c (Fig. IB and Table 1). 
This did not occur in mitochondria isolated from cells coex-
pressing Bax and BC1-XL, whereas, as stated above, the 
amount of cytochrome a+a3 was significantly reduced as com-
pared to the wild-type strain. 
We measured the incidence of these alterations on the ac-
tivity of the respiratory chain. As expected, mitochondria iso-
lated from cells expressing Bax presented a dramatically re-
duced oxygen consumption with both external (NADH; 
Table 1) and internal (ethanol; not shown) electron donor. 
Respiration was so limited in mitochondria isolated from 
Bax-expressing cells that it was not stimulated anymore by 
ADP. Similarly, the reduction of ferricyanide by ethanol in 
the presence of cyanide (to inhibit cytochrome c oxidase) was 
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Fig. 4. Kinetics of cytochrome c release in Bax-expressing cells. Sim-
ilar conditions as in Fig. 3. 
markedly reduced, showing that reduced levels of cytochrome 
c per se results in a decrease of the electron transfer rate. On 
the other hand, the rate of electron transfer from ethanol to 
(exogenous) cytochrome c was not altered, thus confirming 
the absence of alteration of the bei complex. 
We also measured the activity of the oligomycin-sensitive 
FoFi-ATPase to confirm that the lack of stimulation of res-
piration by ADP was not caused by an alteration of this 
complex. The ATPase activity and its degree of sensitivity 
to oligomycin (reflecting the attachment of the catalytic ¥χ 
part to the membrane sector Fo) were unaffected by Bax ex-
pression (Table 1). 
Since the mechanical treatments during isolation may have 
affected mitochondria, we investigated whether this release of 
cytochrome c also occurred in whole cells. For this, we pre-
pared spheroplasts, and then permeabilized them with nysta-
tin under conditions known to release cytosolic enzymes but 
which also allow the maintenance of the integrity of intra-
membrane structures such as the mitochondria [16]. We then 
looked for the presence of cytochrome c in the supernatant 
after centrifugation of cells. Results of these experiments are 
depicted in Fig. IC, D and Fig. 3. It appears clearly that a 
large proportion of cytochrome c in Bax-expressing cells is 
now released by nystatin, indicating its cytosolic localization. 
This release is very rapid, since only after 1 h of induction 
50% of the cytochrome c is already in the cytosol (Fig. 4). 
None or negligible amounts of cytochrome c were released in 
the supernatant of wild-type cells, non-induced Bax-expressing 
cells, or cells coexpressing Bax and BC1-XL. We compared the 
effect of Bax-expression to the effect of chloramphenicol, an 
inhibitor of mitochondrial protein synthesis to investigate the 
possibility of a relationship between cytochrome c oxidase 
reduction and cytochrome c release. Although chlorampheni-
col did induce the release of some cytochrome c (only 10-
15%), this was far from the amplitude of the phenomenon 
observed in Bax-expressing cells. 
4. Conclusion 
Data reported in this paper allow us to draw a correlation 
between Bax-induced growth arrest of yeast cells and two 
major alterations in the respiratory chain. 
First, we observe a dramatic decrease of the amount of 
cytochrome a+a3 and thus of the cytochrome c oxidase com-
plex. The latter could be explained by the fact that assembly 
of the complex requires the attachment of both hemes to one 
of the three mitochondrial DNA-encoded subunits. The de-
crease in the amount of this complex is, however, not related 
to a general problem in mitochondrial DNA-encoded protein 
synthesis since activities of the bei complex and the ATPase 
complex (bei has one while ATPase has three subunits en-
coded by mitochondrial DNA) are not altered. 
Second, we observe a release of cytochrome c from mito-
chondria to the cytosol. Although they occur simultaneously, 
this second phenomenon does not appear to have an obvious 
correlation to the first one since chloramphenicol-induced in-
hibition of mitochondrial protein synthesis does not have a 
profound effect on the release of cytochrome c. 
Whatever the mechanism underlying Bax-induced cyto-
chrome c release from mitochondria, it is of special interest 
since such a release occurs in mammalian cells undergoing 
apoptosis and might be the key to the cascade of biochemical 
events that drive cells to programmed cell death [12,13]. Addi-
tionally, we can draw a parallel between the prevention of 
cytochrome c release by Bcl-2 in mammalian cells and the 
prevention by BC1-XL that we observe in yeast cells. This 
means that, although yeast cells do not have the 'genetic back-
ground' required for the late steps of apoptosis (Bax expres-
sion in yeast does not induce any apoptosis-associated char-
acteristic such as DNA-fragmentation [7]), yet the expression 
of Bax is able to elicit the early steps of apoptosis. Yeast may 
therefore be a suitable model for studying the molecular 
mechanism of the action of genes of the Bcl-2 family. 
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